Changes coming to U.S. import regulations, effective August 29th, 2025. All shipments may be affected. Read more for continued updates.
			
		
			Aug 4, 2025
Verzenio (Abemaciclib) is an oral prescription medication used to treat certain types of advanced or metastatic breast cancer, including hormone receptor-positive (HR+), HER2-negative cases. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which play a role in cell division. Verzenio is often prescribed in combination with other...
Read More
			
		
			Jul 24, 2025
Xtandi (Enzalutamide) is a prescription oral medication used to treat prostate cancer that is metastatic and/or resistant to standard hormone therapy. It works by blocking the effects of androgens (male hormones), which fuel the growth of prostate cancer cells. Xtandi is often used in combination with other therapies and is typically taken daily in...
Read More
			
		
			Jul 21, 2025
Verquvo (Vericiguat) is a prescription oral medication used to reduce the risk of cardiovascular death and hospitalization in adults with symptomatic chronic heart failure and reduced ejection fraction. It works by stimulating soluble guanylate cyclase (sGC), an enzyme in the heart and blood vessels that helps regulate blood flow and reduce strain...
Read More
			
		
			Jul 17, 2025
Vyndamax (Tafamidis) is a prescription oral medication used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive and life-threatening condition caused by deposits of misfolded transthyretin proteins in the heart. It works by stabilizing the transthyretin protein to prevent these deposits from forming.Without insurance, Vyndamax...
Read More
			
		
			Jul 14, 2025
Kisqali (Ribociclib) is an oral prescription medication used in combination with an aromatase inhibitor or fulvestrant for the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It belongs to a class of drugs called CDK4/6 inhibitors, which work by slowing cancer cell growth.Without insurance, Kisqali...
Read More
			
		
			Jul 10, 2025
Mavenclad (Cladribine) is an oral prescription medication used to treat relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS). It is a disease-modifying therapy (DMT) that works by selectively targeting certain white blood cells involved in the immune system’s attack on...
Read More
			
		
			Jul 7, 2025
Xiidra (Lifitegrast) is a prescription eye drop used to treat the signs and symptoms of dry eye disease. It works by targeting inflammation on the surface of the eye, which is believed to be a major cause of dry eye symptoms. Xiidra is typically prescribed as a long-term treatment, with one drop applied to each eye twice daily.Without insurance,...
Read More
			
		
			Jul 3, 2025
Lumakras (Sotorasib) is a prescription oral medication used to treat adults with non-small cell lung cancer (NSCLC) that has a specific KRAS G12C mutation. It is typically prescribed when the cancer has spread or cannot be surgically removed and after the patient has received at least one prior therapy. Lumakras (Sotorasib) targets cancer cells by...
Read More
			
		
			Jun 30, 2025
Olumiant (Baricitinib) is an oral prescription medication approved to treat several inflammatory conditions, including moderate-to-severe rheumatoid arthritis (RA) and severe alopecia areata, in adults. It works by inhibiting Janus kinase (JAK) enzymes, which play a key role in the immune response associated with inflammation.Without insurance,...
Read More